Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review

Ranasinghe, P.; Mathangasinghe, Y.; Jayawardena, R.; Hills, A. P.; Misra, A.

doi:10.1186/s12889-017-4041-1

BMC Public Health

Table 2 Prevalence of metabolic syndrome

From: Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review

Country	Study details (Study date; Study setting; Sample size; Age group)	Metabolic Syndrome definition	Prevalence of metabolic syndrome [95% CI]
Country		Metabolic Syndrome definition	All adults	Males	Females
Australia [22]	2004–2006; Rural; N – 1563; 25–74 years	IDF	35.8^ab [NR]	39.0^b [NR]	33.0^b [NR]
China	2009; National; N – 7488; > 18 years	NCEP ATP III	21.3 [20.4–22.2]	20.9 [19.5–22.2]	21.7 [20.4–23.0]
China	2009; National; N – 7488; > 18 years	IDF	18.2 [17.3–19.1]	16.2 [15.0–17.4]	20.0 [18.8–21.2]
India [23, 27]	2005; Rural; N – 4535; > 30 years	NCEP ATP III	24.6 [21.7–27.5]^b	26.9 [24.3–32.9]^a	18.4 [16.7–24.1]^a
	2007; Urban; N – 2225; > 20 years	NCEP ATP III	16.9 [NR]	27.7^b[NR]	43.2^b [NR]
	2007; Urban; N – 2225; > 20 years	IDF	19.4 [NR]	31.8^b [NR]	47.2^b [NR]
Indonesia [42]	2006; Urban; N – 1591; 25–64 years	Modified NCEP ATP III	28.4^b [NR]	25.4^b [NR]	30.4^b [NR]
Japan [24]	2004; Urban; N – 2321; 40–87 years	NCEP ATP III	16.5^b [NR]	17.2^b [NR]	16.0^b [NR]
Macau [26]	2006; National; N – 1592; 18–44 years	IDF	NR	10.5 [NR]	3.7 [NR]
Malaysia [19]	2008; National; N – 4341; > 18 years	NCEP ATP III	34.3^b [32.9–35.8]	31.1^b [28.8–33.5]	36.1^b [34.3–37.9]
Malaysia [19]	2008; National; N – 4341; > 18 years	IDF	37.1^b [35.6–38.5]	32.1^b [29.8–34.5]	39.8^b [38.0–41.6]
Mongolia [31]	2009; National; N – 1911 > 40 years	IDF	32.8^b [NR]	19.2^b [NR]	40.9^b [NR]
Pakistan [18]	2004; Urban; N – 363; > 25 years	IDF	34.8 [29.7–39.9]	31.8 [22.7–40.9]	36.1 [29.9–42.3]
Pakistan [18]	2004; Urban; N – 363; > 25 years	Modified NCEP ATP III	49.0 [43.8–54.1]	55.6 [46.5–64.7]	45.9 [39.7–52.1]
Philippine [17]	2003;National; N – 4753; > 20 years	NCEP ATP III	11.9 [10.6–13.2]	10.5 [8.8–12.2]	13.4 [11.6–15.2]
Philippine [17]	2003;National; N – 4753; > 20 years	IDF	14.5 [13.1–16.0]	11.8 [10.1–13.6]	17.4 [15.3–19.5]
Singapore [43]	1998; National; N – 4723; 18–69 years	IDF	20.2 [NR]	NR	NR
Singapore [43]	1998; National; N – 4723; 18–69 years	AHA/NHLBI	26.9 [NR]	NR	NR
South Korea [20]	2011–2012; National; N – 9650; > 19 years	AHA/NLHBI	31.3^a [NR]	NR	NR
Sri Lanka [30]	2005–2006; National; N – 4485; > 18 years	IDF	24.3 [23.0–25.6]	18.4 [16.5–20.3]	28.3 [26.6–30.0]
Taiwan [33]	2005–2008; National; N – 2787; > 18 years	Modified NCEP ATP III	25.5 [NR]	25.5^ab [NR]	31.5^ab [NR]
Vietnam [44]	2011; Rural; N – 2443; 40–64 years	Modified NCEP ATP III	16.3 [14.0 − 18.6]	13.9 [11.5 − 16.2]	18.5 [16.3 − 20.7]

CI Confidence Interval, NR Not Reported
^aCalculated using the available data; ^bCrude Prevalence

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com